Want to see RPID full AI Analyst Report?
Total Valuation
Rapid Micro Biosystems has a market cap or net worth of $84.27M. The enterprise value is $87.22.
Market Cap$84.27M
Enterprise Value$87.22
Share Statistics
Rapid Micro Biosystems has 45,660,027 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,660,027
Owned by Insiders32.78%
Owned by Institutions32.92%
Financial Efficiency
Rapid Micro Biosystems’s return on equity (ROE) is -1.42 and return on invested capital (ROIC) is -82.19%.
Return on Equity (ROE)-1.42
Return on Assets (ROA)-0.63
Return on Invested Capital (ROIC)-82.19%
Return on Capital Employed (ROCE)-0.84
Revenue Per Employee196.42K
Profits Per Employee-275.57K
Employee Count171
Asset Turnover0.45
Inventory Turnover1.48
Valuation Ratios
The current PE Ratio of Rapid Micro Biosystems is ―. Rapid Micro Biosystems’s PEG ratio is 0.99.
PE Ratio―
PS Ratio3.86
PB Ratio3.90
Price to Fair Value3.90
Price to FCF-4.06
Price to Operating Cash Flow-1.97
PEG Ratio0.99
Income Statement
In the last 12 months, Rapid Micro Biosystems had revenue of 33.59M and earned -47.12M in profits. Earnings per share was -1.05.
Revenue33.59M
Gross Profit7.61M
Operating Income-47.39M
Pretax Income-47.08M
Net Income-47.12M
EBITDA-42.74M
Earnings Per Share (EPS)-1.05
Cash Flow
In the last 12 months, operating cash flow was -40.06M and capital expenditures -336.00K, giving a free cash flow of -40.39M billion.
Operating Cash Flow-40.06M
Free Cash Flow-40.39M
Free Cash Flow per Share-0.88
Dividends & Yields
Rapid Micro Biosystems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change-36.36%
50-Day Moving Average1.85
200-Day Moving Average2.85
Relative Strength Index (RSI)39.74
Average Volume (3m)253.56K
Important Dates
Rapid Micro Biosystems upcoming earnings date is Nov 5, 2026, After Close (Confirmed).
Last Earnings DateAug 7, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Rapid Micro Biosystems as a current ratio of 3.31, with Debt / Equity ratio of 132.29%
Current Ratio3.31
Quick Ratio2.36
Debt to Market Cap0.15
Net Debt to EBITDA-0.09
Interest Coverage Ratio-43.48
Taxes
In the past 12 months, Rapid Micro Biosystems has paid 40.00K in taxes.
Income Tax40.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Rapid Micro Biosystems EV to EBITDA ratio is -3.12, with an EV/FCF ratio of -4.18.
EV to Sales3.97
EV to EBITDA-3.12
EV to Free Cash Flow-4.18
EV to Operating Cash Flow-4.30
Balance Sheet
Rapid Micro Biosystems has $19.77M in cash and marketable securities with $23.48M in debt, giving a net cash position of -$3.71M billion.
Cash & Marketable Securities$19.77M
Total Debt$23.48M
Net Cash-$3.71M
Net Cash Per Share-$0.08
Tangible Book Value Per Share$0.74
Margins
Gross margin is 10.03%, with operating margin of -141.10%, and net profit margin of -140.30%.
Gross Margin10.03%
Operating Margin-141.10%
Pretax Margin-140.18%
Net Profit Margin-140.30%
EBITDA Margin-127.25%
EBIT Margin-136.94%
Analyst Forecast
The average price target for Rapid Micro Biosystems is $6.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.67
Price Target Upside235.01% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast16.13%
EPS Growth Forecast-11.56%